| Dr Philip Joseph King, DDS | |
|
Psc 475 , Box 1821, Us Naval Hospital Yokosuka, Fpo, AP 96350- 1821 | |
| (011) 814-68962800 | |
| Not Available |
| Full Name | Dr Philip Joseph King |
|---|---|
| Gender | Male |
| Speciality | Dentist - Periodontics |
| Location | Psc 475 , Box 1821, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043202278 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0300X | Dentist - Periodontics | 4120 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Philip Joseph King, DDS Psc 475 , Box 1821, Us Naval Hospital Yokosuka, Fpo, AP 96350- 1821 Ph: (011) 814-68962800 | Dr Philip Joseph King, DDS Psc 475 , Box 1821, Us Naval Hospital Yokosuka, Fpo, AP 96350- 1821 Ph: (011) 814-68962800 |
News Archive
Hoya Corporation today announced financial results for the third quarter ended December 31, 2009. Net sales were 106.8 billion yen for the quarter, a 5.2% decrease from 112.7 billion yen in the same period last year. Operating income was 18.9 billion yen, a 13.8% increase from 16.6 billion yen in the same period last year, mainly due to increase in orders and productivity. Compared to the second quarter ended September 30, 2009, sustained recovery in orders since April resulted in an increase of both net sales and operating income.
New evidence by University of Alabama at Birmingham researchers that specific electromagnetic fields can safely block the proliferation of cancer cells and tumor growth may help refine a new, targeted therapy without any collateral damage.
Over 400 common disinfectants currently in use could be made safer for people and the environment and could better fight the COVID-19 virus with the simple application of UVC light, a new study from the University of Waterloo shows.
Avedro, Inc. announced today that the Company submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for its VibeX (riboflavin ophthalmic solution) /KXL System for the treatment of keratoconus and corneal ectasia following refractive surgery.
› Verified 6 days ago
Dr. Anthony James Marin, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 315-243-5069 | |
Kenneth Andrew Millard, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3d Den Bn 3d Mlg Unit 38450, Fpo, AP 96373 Phone: 315-645-2390 | |
Dr. Miriam Behpour, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 315-243-7144 | |
Jyotirmaie Suryadevara, DMD, MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3d Den Bn 3d Mlg Unit 38450, Fpo, AP 96373 Phone: 973-641-5433 | |
Dr. Trey Jeremy Coke, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: Psc 477 Box 2, Fpo, AP 96306 Phone: 954-618-3286 | |
Dr. Aaron Glen Hassell, Dentist Medicare: Not Enrolled in Medicare Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 816-243-3506 |